AIM AND SCOPE
The Japanese Journal of Oncology and Clinical Research aims to serve as a leading international platform for the publication of high-quality research articles, clinical studies, case reports, and scholarly reviews in all areas of oncology and cancer-related sciences. The journal is dedicated to advancing scientific understanding of cancer biology, tumor progression, diagnosis, prevention, and treatment, with the ultimate goal of improving patient outcomes and enhancing survival and quality of life.
The journal also focuses on promoting innovative and translational research in medical, surgical, radiation, and experimental oncology, including emerging areas such as immunotherapy, precision medicine, targeted therapies, and biomarker discovery. It encourages interdisciplinary collaboration among researchers, clinicians, academicians, and healthcare professionals worldwide, fostering the exchange of knowledge and supporting ethical, rigorous research that contributes to advancements in cancer care and clinical practice.
Scope of the journal
The Japanese Journal of Oncology and Clinical Research covers a broad spectrum of topics within oncology, cancer biology, and clinical cancer research. The primary areas of interest include, but are not limited to, the following:
Medical oncology, surgical oncology, radiation oncology, molecular oncology, experimental oncology, cancer biology, tumor biology, tumor immunology, cancer genetics, oncogenomics, cancer epigenetics, cancer metabolism, cancer stem cells, tumor microenvironment, angiogenesis, metastasis, carcinogenesis, and mechanisms of tumor progression. The journal also includes research on hematologic malignancies, solid tumors, rare cancers, pediatric cancers, gynecologic cancers, gastrointestinal cancers, hepatobiliary cancers, thoracic cancers, head and neck cancers, urologic cancers, skin cancers, and neuro-oncology.
Additional areas include cancer diagnostics, cancer biomarkers, liquid biopsy, molecular diagnostics, histopathology, cytopathology, imaging in oncology, radiomics, and artificial intelligence in cancer detection. Therapeutic research topics include chemotherapy, targeted therapy, immunotherapy, hormone therapy, radiotherapy, combination therapy, precision oncology, personalized medicine, nanomedicine in cancer treatment, cancer vaccines, CAR-T cell therapy, gene therapy in oncology, and emerging experimental therapies.
The journal also emphasizes translational oncology, clinical trials, drug discovery and development, pharmacogenomics in cancer therapy, cancer pharmacology, resistance mechanisms to therapy, relapse and recurrence studies, survivorship research, palliative care, pain management in cancer patients, and supportive oncology care.
Preventive oncology is another key focus area, including cancer epidemiology, cancer prevention strategies, environmental and lifestyle risk factors, occupational exposures, infectious causes of cancer, and public health oncology. Studies on screening programs, early detection methods, population-based cancer studies, and health disparities in cancer care are also encouraged.
The journal welcomes computational and data-driven approaches such as bioinformatics in oncology, cancer systems biology, big data analytics, machine learning applications in cancer research, and integration of multi-omics data including genomics, transcriptomics, proteomics, and metabolomics in cancer studies.
Types of Manuscripts
The journal accepts original research articles, review articles, systematic reviews, meta-analyses, case reports, case series, short communications, clinical trials, technical notes, and letters to the editor.
Global Perspective and Inclusivity
The Japanese Journal of Oncology and Clinical Research encourages submissions from researchers and clinicians worldwide. Cancer is a global health challenge with regional variations in incidence, risk factors, and treatment outcomes. The journal promotes international collaboration and comparative oncology studies that highlight differences across populations and healthcare systems.
Ethical, Legal, and Social Considerations
The journal emphasizes ethical conduct in cancer research and clinical practice. Topics such as informed consent, patient confidentiality, ethical approval for clinical trials, genetic data protection, equitable access to cancer care, and ethical issues in experimental therapies are strongly encouraged. Authors are expected to adhere to international ethical standards in all submissions.
Education and Knowledge Dissemination
The journal aims to serve as an educational platform for oncologists, researchers, students, and healthcare professionals. It encourages review articles and educational content that simplify complex oncological concepts and support continuous professional development in cancer research and clinical practice.
Quality, Integrity, and Scientific Rigor
Maintaining high scientific standards is a core principle of the journal. All submissions undergo rigorous peer review to ensure originality, methodological accuracy, and scientific validity. Authors are expected to present transparent, reproducible, and well-documented research findings.
Collaborative and Interdisciplinary Research
The journal promotes multidisciplinary and collaborative research involving oncologists, pathologists, geneticists, bioinformaticians, pharmacologists, and public health experts. Such collaborations are essential for advancing cancer research and improving clinical outcomes.
Adaptability to Advancing Science
The field of oncology is rapidly evolving with continuous advancements in diagnostics, therapeutics, and technology. The journal remains committed to incorporating emerging areas such as artificial intelligence in oncology, novel immunotherapies, and next-generation sequencing applications in cancer research.
